openPR Logo
Press release

Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031

09-18-2025 01:41 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Lucintel

MRD Testing Market

MRD Testing Market

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.
Within this market, hospitals and specialty clinics will remain the largest segment.
Download sample by clicking on MRD testing market
APAC is expected to witness highest growth over the forecast period.
Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hi-Fi System Market
Bearing for Mechanical and Electrical Product
Telecom Electronic Manufacturing Service Market
Timing Device Market
Visual Inspection Microscope Market
Construction Waste Crusher Market

8951 Cypress Waters Blvd, Suite 160 Dallas, TX 75019, USA
Tel: +1-972-636-5056

Lucintel is the one of the world's most reputed market research report company which provides market intelligence services that free up your market research and strategic planning resources (time, money and people) and allows you to focus on your core business. We assist you in the utilization of the best market intelligence for greater business gains and we do it faster, better and cheaper. Lucintel offers unmatched data and report quality as compared to the other market research report companies with highest customer satisfaction. Browse market research reports by the below sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031 here

News-ID: 4187352 • Views:

More Releases from Lucintel

Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 billion by 2030
Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 b …
According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 billion by 2030
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 bil …
According to a market report by Lucintel, the future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 from $5.5 billion in 2024, at a CAGR of 5.5% from 2024 to 2030. The major drivers for
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to Reach $18.1 billion by 2030
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to R …
According to a market report by Lucintel, the future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030 from $13.5 billion in 2024, at a CAGR of 5.0% from 2024 to 2030. The major drivers for this market are increasing government initiatives
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 billion by 2030
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 bil …
According to a market report by Lucintel, the future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.3 billion by 2030 from $1.5 billion in 2024, at a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing prevalence

All 5 Releases


More Releases for MRD

MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology
Minimal Residual Disease (MRD) Testing Market Booming with Hemato-Oncology Focus …
Minimal Residual Disease (MRD) Testing Market Snapshot The Minimal Residual Disease (MRD) Testing Market is projected to grow from USD 2.58 billion in 2025 to USD 5.64 billion by 2032, at a CAGR of 11.8% during the forecast period. Coherent Market Insights proudly presents its latest Minimal Residual Disease (MRD) Testing Market Research Report, delivering a detailed examination of the U.S. Minimal Residual Disease (MRD) Testing Market outlook from 2025 to 2032.
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. According to a market report by Lucintel, the future
Global MRD Testing Market Set to Reach USD 3.72 Billion by 2030
➤ Global Minimal Residual Disease (MRD) Testing Market to Reach USD 3.72 Billion by 2030, Driven by Technological Advancements and Rising Cancer Incidence The global Minimal Residual Disease (MRD) Testing Market is projected to expand from USD 1.60 billion in 2023 to USD 3.72 billion by 2030, registering a robust Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period. ➤ Competitive Landscape and Regional Demand The MRD testing market
MRD Testing  Market Projected To Witness Substantial Growth, 2024-2031
The Latest research report on the MRD Testing Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the MRD Testing Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies,